User login
The role of moisturizers and lubricants in genitourinary syndrome of menopause and beyond
Michael L. Krychman, MD
Executive Director, Southern California Center for Sexual Health and Survivorship Medicine
Newport Beach, California
Alyssa Dweck, MD
CareMount Medical, PC, Mt. Kisco, New York
Assistant Clinical Professor, Department of Obstetrics, Gynecology, and Reproductive Science
Mount Sinai School of Medicine, New York, New York
Consultant, Massachusetts General Hospital, Vincents Memorial Ob/Gyn Service
Boston, Massachusetts
Sheryl Kingsberg, PhD
Chief, Division of Behavioral Medicine, Department of Obstetrics & Gynecology
University Hospitals, Cleveland Medical Center
Professor, Reproductive Biology and Psychiatry
Case Western Reserve University School of Medicine
Cleveland, Ohio
Lisa Larkin, MD
President, Lisa Larkin, MD, & Associates
Cincinnati, Ohio
Dr. Krychman reports receiving research support from New England Research Institutes (NERI) and being a consultant for Palatin, Shionogi, Inc, Sylk USA, TherapeuticsMD, and Valeant Pharmaceuticals; a speaker for Shionogi and Valeant; and an advisor for Uniderm.
Dr. Dweck reports being a consultant to Uniderm and a speaker for Bayer Pharmaceuticals.
Dr. Kingsberg reports receiving grant or research support from Palatin; being a consultant to Acerus, AMAG, Emotional Brain, EndoCeutics, Materna, NovoNordisk, Nuelle, Palatin, Pfizer, Scientific Strategic Solutions, Shionogi, TherapeticsMD, and Valeant Pharmaceuticals; and being a speaker for Valeant.
Dr. Larkin reports being a consultant and speaker for Valeant Pharmaceuticals.
OBG Management and the roundtable faculty do not endorse any specific product mentioned over another in this roundtable discussion.
Michael L. Krychman, MD
Executive Director, Southern California Center for Sexual Health and Survivorship Medicine
Newport Beach, California
Alyssa Dweck, MD
CareMount Medical, PC, Mt. Kisco, New York
Assistant Clinical Professor, Department of Obstetrics, Gynecology, and Reproductive Science
Mount Sinai School of Medicine, New York, New York
Consultant, Massachusetts General Hospital, Vincents Memorial Ob/Gyn Service
Boston, Massachusetts
Sheryl Kingsberg, PhD
Chief, Division of Behavioral Medicine, Department of Obstetrics & Gynecology
University Hospitals, Cleveland Medical Center
Professor, Reproductive Biology and Psychiatry
Case Western Reserve University School of Medicine
Cleveland, Ohio
Lisa Larkin, MD
President, Lisa Larkin, MD, & Associates
Cincinnati, Ohio
Dr. Krychman reports receiving research support from New England Research Institutes (NERI) and being a consultant for Palatin, Shionogi, Inc, Sylk USA, TherapeuticsMD, and Valeant Pharmaceuticals; a speaker for Shionogi and Valeant; and an advisor for Uniderm.
Dr. Dweck reports being a consultant to Uniderm and a speaker for Bayer Pharmaceuticals.
Dr. Kingsberg reports receiving grant or research support from Palatin; being a consultant to Acerus, AMAG, Emotional Brain, EndoCeutics, Materna, NovoNordisk, Nuelle, Palatin, Pfizer, Scientific Strategic Solutions, Shionogi, TherapeticsMD, and Valeant Pharmaceuticals; and being a speaker for Valeant.
Dr. Larkin reports being a consultant and speaker for Valeant Pharmaceuticals.
OBG Management and the roundtable faculty do not endorse any specific product mentioned over another in this roundtable discussion.
Michael L. Krychman, MD
Executive Director, Southern California Center for Sexual Health and Survivorship Medicine
Newport Beach, California
Alyssa Dweck, MD
CareMount Medical, PC, Mt. Kisco, New York
Assistant Clinical Professor, Department of Obstetrics, Gynecology, and Reproductive Science
Mount Sinai School of Medicine, New York, New York
Consultant, Massachusetts General Hospital, Vincents Memorial Ob/Gyn Service
Boston, Massachusetts
Sheryl Kingsberg, PhD
Chief, Division of Behavioral Medicine, Department of Obstetrics & Gynecology
University Hospitals, Cleveland Medical Center
Professor, Reproductive Biology and Psychiatry
Case Western Reserve University School of Medicine
Cleveland, Ohio
Lisa Larkin, MD
President, Lisa Larkin, MD, & Associates
Cincinnati, Ohio
Dr. Krychman reports receiving research support from New England Research Institutes (NERI) and being a consultant for Palatin, Shionogi, Inc, Sylk USA, TherapeuticsMD, and Valeant Pharmaceuticals; a speaker for Shionogi and Valeant; and an advisor for Uniderm.
Dr. Dweck reports being a consultant to Uniderm and a speaker for Bayer Pharmaceuticals.
Dr. Kingsberg reports receiving grant or research support from Palatin; being a consultant to Acerus, AMAG, Emotional Brain, EndoCeutics, Materna, NovoNordisk, Nuelle, Palatin, Pfizer, Scientific Strategic Solutions, Shionogi, TherapeticsMD, and Valeant Pharmaceuticals; and being a speaker for Valeant.
Dr. Larkin reports being a consultant and speaker for Valeant Pharmaceuticals.
OBG Management and the roundtable faculty do not endorse any specific product mentioned over another in this roundtable discussion.
The Cardiovascular Safety of Nonsteroidal Anti-Inflammatory Drugs: Putting the Evidence in Perspective
Topics Include:
- Key Prospective Clinical Trials
- Danish Registry Study
- Meta-Analyses
- FDA Actions
- PRECISION Trial
Faculty/Faculty Disclosure:
Martin Quan, MD
Professor of Clinical Family Medicine
David Geffen School of Medicine at UCLA
Vice Chair for Academic Affairs
UCLA Department of Family Medicine
Los Angeles, CA
Dr. Quan discloses that he has no real or apparent conflicts to report.
Topics Include:
- Key Prospective Clinical Trials
- Danish Registry Study
- Meta-Analyses
- FDA Actions
- PRECISION Trial
Faculty/Faculty Disclosure:
Martin Quan, MD
Professor of Clinical Family Medicine
David Geffen School of Medicine at UCLA
Vice Chair for Academic Affairs
UCLA Department of Family Medicine
Los Angeles, CA
Dr. Quan discloses that he has no real or apparent conflicts to report.
Topics Include:
- Key Prospective Clinical Trials
- Danish Registry Study
- Meta-Analyses
- FDA Actions
- PRECISION Trial
Faculty/Faculty Disclosure:
Martin Quan, MD
Professor of Clinical Family Medicine
David Geffen School of Medicine at UCLA
Vice Chair for Academic Affairs
UCLA Department of Family Medicine
Los Angeles, CA
Dr. Quan discloses that he has no real or apparent conflicts to report.
Rare Neurological Disease Special Report
Click here to download the digital edition. 
Click here to download the digital edition.
Click here to download the digital edition.
Neuromyelitis Optica Spectrum Disorders: Critical Role of Complement-Dependent Cytotoxicity
Critical Role of Complement-Dependent Cytotoxicity
The complement system was once thought to have a fairly limited role in the immune system, recognizing and eliminating pathogens. Now, however, complement proteins are known to have a much broader role in immunity, and dysregulation of the complement system has been shown to affect the pathogenesis and clinical picture of several autoimmune diseases. This supplement discusses the role of complement-dependent cytotoxicity in the pathophysiology of neuromyelitis optica spectrum disorders.
Click here to read the supplement
US/UNB-NMO/17/0002c
The complement system was once thought to have a fairly limited role in the immune system, recognizing and eliminating pathogens. Now, however, complement proteins are known to have a much broader role in immunity, and dysregulation of the complement system has been shown to affect the pathogenesis and clinical picture of several autoimmune diseases. This supplement discusses the role of complement-dependent cytotoxicity in the pathophysiology of neuromyelitis optica spectrum disorders.
Click here to read the supplement
US/UNB-NMO/17/0002c
The complement system was once thought to have a fairly limited role in the immune system, recognizing and eliminating pathogens. Now, however, complement proteins are known to have a much broader role in immunity, and dysregulation of the complement system has been shown to affect the pathogenesis and clinical picture of several autoimmune diseases. This supplement discusses the role of complement-dependent cytotoxicity in the pathophysiology of neuromyelitis optica spectrum disorders.
Click here to read the supplement
US/UNB-NMO/17/0002c
Critical Role of Complement-Dependent Cytotoxicity
Critical Role of Complement-Dependent Cytotoxicity
The Benefits and Risks of Oral Antiplatelet Therapy in Patients With Acute Coronary Syndrome
The Cardiovascular Insights for Primary Care Physicians eNewsletter Series summarizes key information and data on common cardiovascular issues facing primary care physicians today.
The Cardiovascular Insights for Primary Care Physicians eNewsletter Series summarizes key information and data on common cardiovascular issues facing primary care physicians today.
The Cardiovascular Insights for Primary Care Physicians eNewsletter Series summarizes key information and data on common cardiovascular issues facing primary care physicians today.
Elements for Success in Managing Type 2 Diabetes With SGLT-2 Inhibitors
Faculty/Faculty Disclosure
Eden M. Miller, DO
Executive Director and Co-founder, Diabetes Nation
High Lakes Health Care
St. Charles Hospital
Bend, Oregon
Competing Interest and Financial Disclosures: Dr. Miller discloses that she is on the advisory boards and speakers’ bureaus for AstraZeneca, Eli Lilly and Company, and Janssen Pharmaceuticals, Inc.
Faculty/Faculty Disclosure
Eden M. Miller, DO
Executive Director and Co-founder, Diabetes Nation
High Lakes Health Care
St. Charles Hospital
Bend, Oregon
Competing Interest and Financial Disclosures: Dr. Miller discloses that she is on the advisory boards and speakers’ bureaus for AstraZeneca, Eli Lilly and Company, and Janssen Pharmaceuticals, Inc.
Faculty/Faculty Disclosure
Eden M. Miller, DO
Executive Director and Co-founder, Diabetes Nation
High Lakes Health Care
St. Charles Hospital
Bend, Oregon
Competing Interest and Financial Disclosures: Dr. Miller discloses that she is on the advisory boards and speakers’ bureaus for AstraZeneca, Eli Lilly and Company, and Janssen Pharmaceuticals, Inc.
2017 Directory of VA and DoD Facilities
Control of COPD Symptoms: Addressing an Unmet Need
This series for primary care physicians covers key topics in the management of chronic obstructive pulmonary disease (COPD) and asthma within the context of current national guidelines and clinical practice.
Click here to read the supplement
Randall Brown, MD, MPH, AE-C
Center for Managing Chronic Disease
University of Michigan, Ann Arbor
This series for primary care physicians covers key topics in the management of chronic obstructive pulmonary disease (COPD) and asthma within the context of current national guidelines and clinical practice.
Click here to read the supplement
Randall Brown, MD, MPH, AE-C
Center for Managing Chronic Disease
University of Michigan, Ann Arbor
This series for primary care physicians covers key topics in the management of chronic obstructive pulmonary disease (COPD) and asthma within the context of current national guidelines and clinical practice.
Click here to read the supplement
Randall Brown, MD, MPH, AE-C
Center for Managing Chronic Disease
University of Michigan, Ann Arbor
